These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 25027463

  • 1. [Topiramate in substance-related and addictive disorders].
    Cohen J, Dervaux A, Laqueille X.
    Presse Med; 2014 Sep; 43(9):892-901. PubMed ID: 25027463
    [Abstract] [Full Text] [Related]

  • 2. Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features.
    Nourredine M, Jurek L, Angerville B, Longuet Y, de Ternay J, Derveaux A, Rolland B.
    CNS Drugs; 2021 Feb; 35(2):177-213. PubMed ID: 33591567
    [Abstract] [Full Text] [Related]

  • 3. Topiramate in the treatment of substance-related disorders: a critical review of the literature.
    Shinn AK, Greenfield SF.
    J Clin Psychiatry; 2010 May; 71(5):634-48. PubMed ID: 20361908
    [Abstract] [Full Text] [Related]

  • 4. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
    Dalai SS, Adler S, Najarian T, Safer DL.
    Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
    [Abstract] [Full Text] [Related]

  • 5. Treatment of binge-eating disorder with topiramate: a clinical case series.
    Shapira NA, Goldsmith TD, McElroy SL.
    J Clin Psychiatry; 2000 May; 61(5):368-72. PubMed ID: 10847312
    [Abstract] [Full Text] [Related]

  • 6. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
    Claudino AM, de Oliveira IR, Appolinario JC, Cordás TA, Duchesne M, Sichieri R, Bacaltchuk J.
    J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
    [Abstract] [Full Text] [Related]

  • 7. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW, Reimherr FW, Hoopes SP, Rosenthal NR, Kamin M, Karim R, Capece JA.
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
    Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O'Brien CP.
    Drug Alcohol Depend; 2013 Nov 01; 133(1):94-9. PubMed ID: 23810644
    [Abstract] [Full Text] [Related]

  • 9. Topiramate for binge-eating disorder associated with obesity.
    Tata AL, Kockler DR.
    Ann Pharmacother; 2006 Nov 01; 40(11):1993-7. PubMed ID: 17047134
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review.
    Arbaizar B, Gómez-Acebo I, Llorca J.
    Gen Hosp Psychiatry; 2008 Nov 01; 30(5):471-5. PubMed ID: 18774432
    [Abstract] [Full Text] [Related]

  • 11. Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial.
    Reis AD, Castro LA, Faria R, Laranjeira R.
    Braz J Psychiatry; 2008 Jun 01; 30(2):132-5. PubMed ID: 18470406
    [Abstract] [Full Text] [Related]

  • 12. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V, Van Kirk J.
    Exp Clin Psychopharmacol; 2002 Aug 01; 10(3):213-27. PubMed ID: 12233982
    [Abstract] [Full Text] [Related]

  • 13. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
    Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, Capece JA, Karvois D.
    J Clin Psychiatry; 2003 Nov 01; 64(11):1335-41. PubMed ID: 14658948
    [Abstract] [Full Text] [Related]

  • 14. The potential interest of topiramate in addiction.
    Thorens G, Billieux J, Manghi R, Khan R, Khazaal Y, Zullino DF.
    Curr Pharm Des; 2011 Nov 01; 17(14):1410-5. PubMed ID: 21524260
    [Abstract] [Full Text] [Related]

  • 15. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.
    McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR, Topiramate Binge Eating Disorder Research Group.
    Biol Psychiatry; 2007 May 01; 61(9):1039-48. PubMed ID: 17258690
    [Abstract] [Full Text] [Related]

  • 16. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
    McElroy SL, Arnold LM, Shapira NA, Keck PE, Rosenthal NR, Karim MR, Kamin M, Hudson JI.
    Am J Psychiatry; 2003 Feb 01; 160(2):255-61. PubMed ID: 12562571
    [Abstract] [Full Text] [Related]

  • 17. Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.
    Brownley KA, Berkman ND, Peat CM, Lohr KN, Cullen KE, Bann CM, Bulik CM.
    Ann Intern Med; 2016 Sep 20; 165(6):409-20. PubMed ID: 27367316
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial.
    García Campayo J, Sobradiel N, Alda M, Mas A, Andrés E, Magallón R, Crucelaegui A, Sanz B.
    BMC Fam Pract; 2008 May 07; 9():28. PubMed ID: 18462502
    [Abstract] [Full Text] [Related]

  • 19. Evidence-based pharmacological treatment of substance use disorders and pathological gambling.
    van den Brink W.
    Curr Drug Abuse Rev; 2012 Mar 07; 5(1):3-31. PubMed ID: 22126708
    [Abstract] [Full Text] [Related]

  • 20. Systematic review of N-acetylcysteine in the treatment of addictions.
    Asevedo E, Mendes AC, Berk M, Brietzke E.
    Braz J Psychiatry; 2014 Mar 07; 36(2):168-75. PubMed ID: 24676047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.